Clayton Smith Selected Research

Clayton Smith Research Topics

8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 10/2016
5	Leukemia 02/2019 - 08/2003
4	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2003
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2013 - 08/2003
3	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2008 - 12/2003
2	COVID-19 02/2022 - 03/2021
2	Cytopenia 01/2021 - 01/2003
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2019
1	Heart Failure 01/2022
1	Severe Acute Respiratory Syndrome 04/2021
1	Infections 03/2021
1	Rectal Neoplasms (Rectal Cancer) 12/2020
1	Cutaneous Fistula 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2018
1	Colorectal Neoplasms (Colorectal Cancer) 11/2017
1	Bronchiolitis Obliterans Syndrome 11/2017
1	Neoplasms (Cancer) 10/2016
1	Disease Progression 01/2016
1	Wounds and Injuries (Trauma) 08/2015
1	Splenomegaly 04/2013
1	Leukocytosis (Pleocytosis) 04/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2009
1	Multiple Myeloma 01/2009
1	Blast Crisis (Blast Phase) 08/2003
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2003

5	venetoclaxIBA 12/2021 - 12/2018
5	Azacitidine (5 Azacytidine)FDA Link 12/2021 - 12/2018
3	VaccinesIBA 02/2022 - 03/2021
3	Filgrastim (Neupogen)FDA Link 11/2017 - 01/2016
3	Pharmaceutical PreparationsIBA 11/2016 - 08/2003
2	Amino Acids FDA Link 02/2019 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 11/2017 - 01/2008
2	parthenolideIBA 11/2016 - 10/2016
2	Proteins (Proteins, Gene)FDA Link 08/2015 - 08/2003
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2007 - 12/2003
1	TESIBA 01/2022
1	Ferritins (Ferritin)IBA 03/2021
1	NanovaccinesIBA 03/2021
1	Broadly Neutralizing AntibodiesIBA 03/2021
1	SARS-CoV-2 spike proteinIBA 03/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2020
1	Lenalidomide (CC 5013)FDA Link 01/2019
1	Aldehyde DehydrogenaseIBA 11/2017
1	InterferonsIBA 11/2017
1	CollagenIBA 08/2015
1	HydrogelsIBA 08/2015
1	EnzymesIBA 04/2013
1	Oncogene Proteins (Oncogene Protein)IBA 04/2013
1	Adenosine DeaminaseIBA 04/2013
1	Tyrosine Kinase InhibitorsIBA 04/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2009
1	plerixafor FDA Link 01/2009
1	SteroidsIBA 12/2003
1	Messenger RNA (mRNA)IBA 08/2003
1	LAQ824IBA 08/2003
1	Hydroxamic Acids (Hydroxamic Acid)IBA 08/2003
1	Imatinib Mesylate (Gleevec)FDA Link 08/2003
1	Histone Deacetylases (Histone Deacetylase)IBA 08/2003
1	Histone Deacetylase InhibitorsIBA 08/2003

4	Drug Therapy (Chemotherapy) 12/2021 - 01/2003
3	Therapeutics 01/2021 - 10/2016
3	Transplantation 01/2020 - 07/2008
2	Homologous Transplantation 01/2017 - 01/2016
1	Induction Chemotherapy 12/2021
1	Chemoradiotherapy 12/2020
1	Cryotherapy (Therapy, Cold) 01/2020
1	Radiotherapy 01/2020
1	Blood Component Removal (Apheresis) 11/2017
1	Time-to-Treatment 01/2016
1	Microspheres (Microsphere) 08/2015